News

The achievement of that goal in India, which ranks third in obesity numbers after the US and China, will shatter the record ...
Greg Abbott’s veto of a bill that his lieutenant governor supported underscores the patchwork nature of regulation of ...
Unites Pharma Marketing, PR & Communications, New Product Planning & Commercialization, and Medical Affairs Communities; ...
Newsweek's AI Impact Award winners share how they measure success and guarantee outcomes: setting themselves apart in a ...
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” ...
Explore innovations in industrial biopolymers and their role in creating sustainable, eco-friendly alternatives for packaging ...
Fueled by a sustained boom in sales of its diabetes and obesity products, Eli Lilly will become the world’s top-seller of prescription drugs by 2030 and will hold the top rung by a wide margin. | ...
For the life sciences sector, the new initiatives are meant to work in concert with the upcoming 10-year plan for the ...
Blending Bold Strategy with Proven Market Access and Health Economics Expertise to Unlock Asset Value YARDLEY, Pa. and LONDON, June 23, 2025 /PRNewswire/ ...
Zacks Investment Research on MSN8hOpinion
HIMS Stock Crashes 30% in a Day: Time to Buy the Dip?
Hims & Hers Health (HIMS) has been one of the market’s standout growth stocks in recent years. The company has successfully ...